Page last updated: 2024-11-04

sarpogrelate and Cardiovascular Diseases

sarpogrelate has been researched along with Cardiovascular Diseases in 4 studies

sarpogrelate: structure given in first source

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"Sarpogrelate has been found to have beneficial effects in peripheral vascular disease, restenosis after coronary stenting, pulmonary hypertension, acute and chronic myocardial infarction."2.42Therapeutic potentials of sarpogrelate in cardiovascular disease. ( Arneja, AS; Dhalla, NS; Goyal, RK; Kumamoto, H; Saini, HK; Takeda, N, 2004)
"Sarpogrelate is a selective 5-hydroxytryptamine receptor subtype 2A (5-HT2A) antagonist."2.42Sarpogrelate: cardiovascular and renal clinical potential. ( Doggrell, SA, 2004)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Marcinkowska, M1
Kubacka, M1
Zagorska, A1
Jaromin, A1
Fajkis-Zajaczkowska, N1
Kolaczkowski, M1
Higashi, Y1
Fujita, M1
Origasa, H1
Miyata, T1
Matsuo, H1
Naritomi, H1
Shigematsu, H1
Saini, HK1
Takeda, N1
Goyal, RK1
Kumamoto, H1
Arneja, AS1
Dhalla, NS1
Doggrell, SA1

Reviews

2 reviews available for sarpogrelate and Cardiovascular Diseases

ArticleYear
Therapeutic potentials of sarpogrelate in cardiovascular disease.
    Cardiovascular drug reviews, 2004,Spring, Volume: 22, Issue:1

    Topics: Animals; Cardiovascular Diseases; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Sero

2004
Sarpogrelate: cardiovascular and renal clinical potential.
    Expert opinion on investigational drugs, 2004, Volume: 13, Issue:7

    Topics: Animals; Cardiovascular Diseases; Humans; Kidney Diseases; Molecular Structure; Succinates

2004

Other Studies

2 other studies available for sarpogrelate and Cardiovascular Diseases

ArticleYear
Exploring the antiplatelet activity of serotonin 5-HT
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 145

    Topics: Animals; Cardiovascular Diseases; Humans; Isoxazoles; Male; Platelet Aggregation; Platelet Aggregati

2022
Study design of SEASON registry: prospective Surveillance of cardiovascular Events in an Antiplatelet-treated arterioSclerosis Obliterans patients in JapaN )SEASON).
    International heart journal, 2010, Volume: 51, Issue:5

    Topics: Arteriosclerosis Obliterans; Cardiovascular Diseases; Humans; Japan; Platelet Aggregation Inhibitors

2010